ArticleJournal of Alzheimer's disease : JAD2014

Brain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic.

Gregory Hook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.